
|Articles|April 1, 2003
Hair Removal Duet
San Francisco -- Topical eflornithine hydrochloride 13.9 percent cream (Vaniqa) can be used safely by patients undergoing laser hair removal and may have added value for improving the response to photoepilation, especially early on, according to results of a double-blinded study presented by Stacy R. Smith, M.D., at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
Dermatology Conferences and Meetings Calendar: December 2025
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5


















